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maintaining high open probabilities.
1470-Pos Board B380
Role of Salt Bridges within the Ligand Binding Domains of NMDA Recep-
tors During Receptor Activation
Meaghan Paganelli, Gabriela K. Popescu.
Glutamatergic synaptic transmission mediated by the N-methyl-D-aspartate
(NMDA) receptor plays a fundamental role in numerous central nervous system
processes, but how the receptor becomes active is insufficiently understood.
Structural studies of isolated ligand-binding domains (LBDs) revealed that ag-
onists bind between two flexible lobes (D1 and D2) and by causing the lobes to
move closer together initiate the activation reaction. In many cases, the efficacy
of the agonist correlates with how narrow the cleft becomes and/or how stable
the closed-cleft conformation is. In NMDA receptors, full-agonists induce
cleft-closure and the formation of new stabilizing electrostatic interactions
across the lobes of soluble LBDs. However, how these interactions contribute
to the kinetics of NMDA receptors is not known. To evaluate the roles of pu-
tative cross-cleft interactions to the activation mechanism of intact receptors,
we eliminated these salt bridges in individual subunits and quantified their ef-
fect on gating by kinetic analyses of single channel traces. We were surprised to
find that: receptors containing GluN1(K483A) and GluN2A(K487A) had activ-
ities that were ~10% higher than wild-type controls; receptors containing
GluN1(K483M) had wild-type activity; and those containing GluN2(N687L)
had activities that were ~30% lower than controls. These results suggest that
at these positions, residue-size as well as the ability to form cross-cleft interac-
tions affect the gating process. They also reveal subtle distinctions between
how residues in the GluN1 and GluN2A LBDs contribute to gating.
1471-Pos Board B381
Constraining Gating Actions of Specific Subunits During NMDA Receptor
Activation
Iehab Talukder, Rashek Kazi, Lonnie P. Wollmuth.
NMDA receptor activation gating initiates at its extracellular ligand-binding
domain (LBD) and culminates in opening of the associated ion channel. Kinet-
ically, this gating transition occurs through sequential intermediaries with at
minimum three pre-open and two open states. The overall gating transition oc-
curs in a concerted manner only after each subunit has bound its respective li-
gand. Functional NMDA receptors, however, are obligate heterotetramers,
typically composed of two glycine-binding GluN1 and two glutamate-binding
GluN2 subunits. To study subunit-specific contributions to gating kinetics, we
constrained relative movements of the M3/M3-S2 central channel gating axis
through intra-subunit disulfide cross-linking of partner positions in the M3-
S2 and S2-M4 LBD-ion channel linkers, GluN1(C,C) and GluN2A(C,C). Anal-
ysis of single-channel recordings revealed the cross-linked receptors to be in-
efficient in activation gating, with a significantly lower Po [mean SEM; 0.02
5 0.005 for GluN1(C,C)-GluN2A vs. 0.61 5 0.05 for GluN1-GluN2A].
This 30-fold reduction in Po is manifested by both a 6-fold decrease in mean
open duration (1.3 5 0.2 vs. 8.3 5 0.7 ms) and an 18-fold increase in mean
closed duration (94 5 20 vs. 5.1 5 0.7 ms). The cross-linked receptors un-
dergo only flickery openings to a short-lived open state (tO1, 0.25 5 0.05
vs. 0.125 0.01 ms) and virtually do not visit the main long-lived (~ 8.7 ms)
open state. Instead, cross-linked receptor activity is locked into two long-lived
pre-open states (tC3, 38 5 9 vs. 4.2 5 0.4; tC4, 208 5 45 vs. 52 5 3 ms).
Thus, GluN1 subunit-specific constraint of its M3/M3-S2 gating axis most
strongly affects the kinetic end states of activation gating, with minimal, if
any, perturbation of the intermediate states. These results support a tightly cou-
pled LBD to ion channel gating machinery in the NMDA receptor.
1472-Pos Board B382
Atp4- Activates P2x Receptors
Mufeng Li, Shai D. Silberberg, Kenton J. Swartz.
P2X receptors are non-selective cation channels that are involved in many im-
portant physiological processes, including neurotransmission and inflamma-
tion. Extracellular ATP released from synaptic vesicles or damaged tissues
has been demonstrated to be the ligand for activating P2X receptors. However,
it is not clear if ATP activates P2X receptors in its free anionic form as ATP4-,
or in complex with divalent cations such as magnesium (MgATP)2-. Here we
examined if ATP can open the channels in the absence of divalent cations,
and tested the effects of different concentrations of Mg2þ on the dose response
curve for channel activation by ATP. The results show that all seven subtypes
of P2X receptors can be activated by ATP4-, and on all but one subtype of P2X
receptor, Mg2þ has a modulatory effect. In the one exception, we found that
Mg2þ competes with P2X receptors for ATP4-, suggesting that (MgATP)2- is
not the agonist. In summary, our results suggest that free ATP, but not magne-
sium bound ATP, is the ligand for opening P2X receptors.1473-Pos Board B383
Application of the Cytopatch Instrument for Compound Screening of
Ligand-Gated ion Channels
Thomas Knott, Gesa Rascher-Eggstein, Olaf Scheel.
Ligand-gated ion channels are in the focus of the pharmaceutical research as
important drug targets, like the family of GABA receptors, 5-HT receptors,
acetylcholine receptors (AChR), P2X receptors or TRP channels. The method
of choice to screen for ligand-gated ion channel modulators is the automated
patch clamp technique but a combination of high data quality and high through-
put is required to carry out successful and efficient compound screens.
Thus, patch clamp screening of ligand-gated ion channels demands of flexible
application schemes and a very rapid ligand application below 50 ms. Further-
more, a fast and complete wash out of agonists is a premise for a good data
quality, because desensitization of some ligand-gated ion channels can lead
to failures in current quantification due to low leftovers of the ligands. This
specification is a big challenge for automated patch clamp instruments, as
very fast movements of microfluidics must be controlled precisely whilst rup-
turing of the cell must be excluded.
Here, we show that the CytoPatch Instrument with its unique application tech-
nique is well suited for the investigation of ligand-gated ion channels: The appli-
cationof agonists is accomplishedwithin 25ms, as shown for the nicotinicAChR
in TE672 cells. Furthermore the investigation of the purinergic P2RX7 receptor
is presented. Desensitization or rundown has not been detected. Offering a fast
and flexible perfusion, the instrument allows to investigate agonistic and antag-
onistic modulation of ligand-gated channels with a data quality similar to that of
the manual patch clamp. With its modular assembly throughput is individually
scalable by the numbers of CytoPatch modules within a screening facility.
1474-Pos Board B384
P2X7 Receptor-Mediated Currents in Rat Hypothalamic Neurohypophy-
sial System Terminals
Adolfo E. Cuadra, Thomas K. Knott, Edward Custer, Jose´ R. Lemos.
ATP facilitates the process of secretion by stimulation of purinergic P2X recep-
tors (P2XR) in secretory cells and neurons. While the expression and function
of the P2X(7)R-subtype in neurons is controversial, studies show that P2x(7)R
mRNA is present in the brain, including in the hypothalamic neurohypophysial
system (HNS). Our laboratory has reported that HNS arginine-vasopressin
(AVP) terminals exhibit P2x(7)R immunoreactivity (IR) along with other
P2xR subtypes, while oxytocin (OT) terminals display only P2X(7) IR. There-
fore, our objective was to characterize P2x7R function in isolated HNS termi-
nals from rat brain.
The P2x(7)R is distinguished from other P2XR types by low sensitivity to ATP
(EC50>100 mM) and potent inhibition by Brilliant Blue-G (BBG;
IC50<<mM). In voltage clamp experiments OT terminals showed negligible
response to 10 mM ATP, an effective dose for other P2XR. In turn, 300 mM
ATP induced a rapidly-activated, slowly-inactivating current that was revers-
ibly inhibited by 300 nM BBG. These results are consistent with P2x(7)R func-
tion in OT terminals. We have reported that AVP containing terminals
generated maximal current with 100 mM ATP that was blocked by the P2XR
inhibitor PPADS (10 mM). Dose-response experiments performed using higher
ATP doses (up to 1 mM) revealed increasing current amplitudes with 300 mM
and 1 mM application in AVP terminals. Subsequent treatment with PPADS
nearly abolished current stimulated at 10 mM ATP. However, 1 mM ATP ap-
plication revealed a resistant current-component of approximately 20 percent
of total. This component was reversibly inhibited by 300 nM BBG. The pres-
ence of low ATP-sensitive currents, which is inhibited by BBG, is consistent
with P2x(7)R function in OT and AVP containing terminals. To our knowledge
this is the first direct evidence of P2x(7)R function shown in neuronal termi-
nals. (supported by NIH grant NS29470 to JRL)
1475-Pos Board B385
Validation of Screening Assays for Ligand Gated ion Channels on Qpatch
HTX
Søren Friis, Mats H. Holmqvist, Lars D. Løjkner, M. Knirke Jensen,
Morten Sunesen.
QPatch HTX has the highest throughput in the QPatch series. With signature
features such as unattended operations, eight pipettes and the integrated micro-
fluidic glass flow channels of the QPlates, the QPatch HTXis well suited for
testing ligand gated ion channels. The recent advent of a QPlate with 10 patch
holes per measurement site, instead of the classical single patch holehas mini-
mized problems with low expression or problems with stability of the recodings
over time. The success rate of recording on QPatch HTX is therefore approach-
ing 100% for a number of different applications. We have previously shown
that compound profiling on a wide variety of ligand-gated ion channels is cer-
tainly possible on the QPatch. With the increased stability and success rates of
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screening tool for ligand gated ion channels. In this study, we have tested 3 dif-
ferent ion channels in a screening assay on QPatch HTX: GABA a1b1g2 (g-
amino butyric acid receptor), ASIC a1 (acid sensing ion channel) and nAchR
a1 (nicotinic acetylcholine receptor). These assays each have their own unique
set of challenges: Low functional expression, extremely high elicited current
amplitudes, and fast desensitization respectively. In this poster we present
data to compare throughput and assay quality between the QPatch HTX in
multi-hole mode and the classic single-hole mode in a screening scenario.
1476-Pos Board B386
Subunit Oligomerization of Human ASIC1a in Xenopus Laevis Oocytes
Delphine Huser, Ivan Gautschi, Aris Maquelin, Miguel van Bemmelen,
Laurent Schild.
The crystal structure of the chicken Acid Sensing Ion Channel 1 (ASIC1) shows
a homotrimeric channel complex. Because of conflicting results regarding the
subunit stoichiometry of other members of the ASIC ion channel family, we
have determined the mass of the functional human ASIC1a channel complex
expressed in Xenopus oocytes.
We have used sulfhydryl crosslinkers or oxidizing agents to stabilize the native
oligomeric ASIC1a complex. In the cut-open oocyte recording system, the in-
tracellular perfusion of 2-20 mM sodium tetrathionate (NaTT) did not affect
hASIC1a activity. Western blot analysis shows that NaTT induces a shift in
the molecular weight of ASIC1a from the monomeric 70 kDa, to higher molec-
ular weights of 140 and 280 kDa. ASIC1a purification after surface biotinyla-
tion and crosslinking shows that the major form of ASIC1a at the plasma
membrane corresponds to a 280 kDa channel complex. The use of different
sulfhydryl crosslinkers allowed to stabilize onWestern blot oligomeric ASIC1a
complexes of 280, 210 and 140 kDa corresponding to tetramers, trimers and di-
mers. This subunit crosslinking of the ASIC1a complex depends on cysteines in
the C-terminus of the protein. We confirmed by size exclusion chromatography
the presence of a hASIC1a channel complex of a mass corresponding approx-
imatively to 280 kDa.
In Xenopus oocytes sulfhydryl crosslinkers or oxidizing reagents stabilized
a hASIC1a complex of 280 kDa without affecting channel activity; the mass
of this channel complex cannot simply account for a trimer. The C-terminus
of ASIC1a subunits is involved in subunit-subunit interactions and may be im-
portant for the oligomerization of the functional channel complex.
This work was supported by a grant from the SNF.
1477-Pos Board B387
Identifying an Etomidate Binding Site in Heterologously Expressed Hu-
man Alpha1/Beta3 GABAA Receptors (GABAAR) Using Photoactive Eto-
midate Analogs
Selwyn S. Jayakar*, Zuzana Dostalova*, David C. Chiara, Xiaojuan Zhou,
Aiping Liu, Keith W. Miller, Jonathan B. Cohen.
The GABAAR is a target for general anesthetics, which act as positive allosteric
modulators at clinical doses. Previously, in a heterogeneous mixture of
GABAARs isolated from bovine brain, [
3H]azietomidate photolabeled amMet-
236 and bnMet-286 (m = 1, 2, 3 or 5; n = 1, 2 or 3) in the aM1 and bM3 trans-
membrane helices. To resolve uncertainties inherent in using natural sources of
receptor, we used stable tetracycline-inducible HEK293 cells overexpressing
a1b3 GABAARs. Furthermore, to explore the proposed site in more detail, we
used two photoactivable etomidate derivatives: [3H]azietomidate, an aliphatic
diazirine, and [3H]TDBzlEtomidate, an aryl diazirine with a broader amino
acid side chain reactivity profile (Figure). Purified recombinant human a1b3
GABAARs, functionally reconstituted into detergent-asolectin, were photola-
beled in the presence of GABA 5 etomidate. [3H]Azietomidate and [3H]
TDBzlEtomidate photolabeled b3Met-286 and a1Met-236, and [3H]TDBzlEto-
midate photolabeled b3Val-290, one helical turn below b3Met-286. These
observations prove that the photola-
beled b- and a-subunits belong to
a single oligomer and strengthen
the hypothesis that the three photola-
beled residues all belong to a single
site within the b-a subunit interface.
(*S.S.J. and Z.D. contributed
equally; supported by GM58448).1478-Pos Board B388
A conserved Asparagine Between Loops A and E of Anion Ligand-Gated
Channels is Critical for Gaba(A) Receptor Function
Riley E.A. Perszyk, Carrie A. Wiliams, Andrew Jenkins.
Cys-loop ligand-gated ion channels are pentameric transmembrane proteins
that are essential for the regulation of neuronal excitability. In synaptic
GABA(A) receptors, residues in the two a-bþ interfaces are known to definethe GABA binding site while homologous residues in the g-aþ interface de-
fine the classical high-affinity benzodiazepine binding site. Very little how-
ever, is known about the structure and function of the remaining two
interfaces: b-aþ and b-gþ. Since the b- interface is common to both, we
chose to investigate the role this interface plays in receptor function, using
the tools of structure-homology modeling, site-directed mutagenesis, transient
expression of receptors in HEK-293 cells and whole-cell patch-clamp electro-
physiology. In this study, we focused on a non-canonical loop domain
(NCLD) that links the canonical loops A and E, also known as the b-strand
5-b- strand 5’ linker. Homology models predict that the N-terminal end of
this loop flanks a large inter-subunit lumen-accessible crevice. An alanine
screen of the NCLD revealed 4 positions within the domain that are critical
for receptor activation. Of particular interest was a highly-conserved aspara-
gine: b2(N113). Our data indicate that mutations at this position results in
reduced receptor sensitivity to GABA (increased EC50), impaired receptor
gating (reduced partial agonist efficacy) and perturbed ion flow (increased
rectification). Interestingly, the change in rectification was reversed by the
addition of positive allosteric modulators such as propofol and pregnanolone.
Taken together, our observations demonstrate the importance of the non-
binding interfaces in controlling receptor function.1479-Pos Board B389
Etomidate Binding Interactions in GABAA Receptor Defined with Cysteine
Substitutions
Deirdre S. Stewart, Aiping Liu, Stuart A. Forman.
The general anesthetic etomidate exerts its major clinical actions through po-
tentiation of GABAA receptor activation. GABAA receptors are pentameric,
usually consisting of combinations of alpha, beta, and gamma subunits. A pho-
toreactive structural analog of etomdiate ([3H]azietomidate) labels amino acids
on transmembrane domains in both a (Met236) and b (Met286) subunits. Con-
sistent with receptor structural homology models based on Torpedo nicotinic
acetylcholine receptor, the labeling results suggests the presence of two inter-
facial anesthetic binding sites per GABAA receptor located at the transmem-
brane b/a subunit interface. However, azietomidate may fail to label other
important binding determinants. In particular, b subunit reside 265 is predicted
to be near the etomidate site, and b2/b3Asn265 mutations profoundly affect
etomidate sensitivity. To determine if specific residues are within the etomidate
site, we tested whether etomidate protects Cysteines substituted at these resi-
dues from sulfhydryl modifying reagents. In human a1b2g2L background,
GABAA receptors with the a1M236C and a1L232C mutations displayed eto-
midate sensitivity similar to wild-type in electrophysiological experiments,
while receptors with b2M286C and b2N265Cmutations largely eliminated eto-
midate effects. All of these Cysteine substituted receptors were modified by p-
chloromercuribenzenesulfonate (pCMBS), which altered electrophysiological
properties. Using allosteric GABA/etomidate co-agonist gating models for
each mutant, we identified protection conditions where the mix of receptor
states was similar to control modification conditions and etomidate site occu-
pancy was expected to be high. In the presence of etomidate, the apparent
rate of pCMBS modification at both a1M236C and b2M286C was reduced
more than ten-fold and was reduced two-fold at a1L232C. In contrast, pCMBS
modification of b2N265C was unaffected by high concentrations of etomidate.
These results suggest that etomidate sterically interacts strongly with
a1Met236 and b2Met286 and weakly with a1Leu232, but does not interact
with b2Asn265.1480-Pos Board B390
A novel Polymorphism Linked to Epilepsy Encoding a Missense Mutation
in the Pre-M1 Region of a6 Subunits Alters the Gating, but not Trafficking,
of GABAa Receptors
Ciria C. Hernandez, Katharine N. Gurba, Ningning Hu, Robert
L. Macdonald.
Charged residues in the pre-M1 region of Cys-loop ligand-gated ion channels
affect current activation, desensitization and deactivation, suggesting that
these interface residues may be involved in coupling agonist binding to chan-
nel gating. Mutations that affect function and/or expression of GABAA recep-
tors (GABARs) have been associated with idiopathic generalized epilepsies
(IGEs). The Parallel Sequence Profiling of Ion Channels in Epilepsy Project
at Baylor College of Medicine funded by NINDS and NHGRI identified
a novel single nucleotide polymorphism encoding a missense mutation,
Q237R, in the GABAR a6 subunit in a patient with an IGE (http://
www.hgsc.bcm.tmc.edu/project-medseq-r-ionchannel.hgsc). Homology mod-
eling suggested that Q237R is located within the b10-M1linker or ‘‘pre-
M1’’ segment of the N-terminal a6 subunit extracellular domain where it
